Introduction
Developmental dysplasia of the hip (DDH) is a common developmental hip disorder, which ranges from mild acetabulum malformation to irreducible hip dislocation [1, 2] . DDH is a main cause of childhood disability and early onset hip osteoarthritis [3] [4] [5] , and an epidemiologic study showed that DDH underlies up to 9% and 29% of all primary hip arthroplasty and those in people younger than 60 years, respectively [6] . DDH is affected by multiple factors including environmental and genetic factors. Family history of DDH, female gender, breech positioning at delivery, and large birth weight are risk factors of DDH [7] . In previous studies, we had detected associations between DDH and single nucleotide polymorphisms (SNPs) in GDF5, TBX4, and ASPN by casecontrol studies in Chinese Han population [8] [9] [10] , and the association between DDH and GDF5 was also found in Caucasians [11] .
Recently, a genome-wide linkage scan was conducted in a four-generation Chinese family of 25 members which includes 5 DDH patients. An association study based on the linkage scan was executed [12] , and a SNP in pregnancyassociated plasma protein-A2 gene (PAPPA2), rs726252, was found to be associated with DDH. PAPPA2 encodes a novel metalloproteinase pregnancy-associated plasma protein-A2 which may play roles in fetal development [13] [14] [15] [16] . In the comparison between 310 DDH patients and 487 control subjects, they detected significant differences of both genotype distribution and allele frequency of rs726252 ( = 0.0014 and 0.0013, resp.). Significant differences of genotype distribution and allele frequency still existed after stratification by gender (female = 0.019 and 0.0079, male = 0.0065 and 0.0035). The study suggested a significant association of PAPPA2 with DDH susceptibility in Chinese Han population. But with the consideration of the sample size, we thought the association between rs726252 and DDH was still debatable. To confirm the association of this SNP with DDH, we conducted a casecontrol study in a larger number of subjects.
Materials and Methods

Subjects.
A total of 1404 subjects including 697 DDH patients and 707 healthy control subjects were enrolled in the study. The patients (594 females and 103 males) were consecutively recruited from the Center of Diagnosis and Treatment for DDH, Kang'ai Hospital, Nanjing, China, and the healthy control subjects (299 females and 408 males) were enrolled from the Physical Examination Center, Drum Tower Hospital Affiliated to Medical School of Nanjing University, China. The patients were diagnosed as unilateral or bilateral DDH by expert medical examination with radiographic evidence. The criteria of defining the severity of DDH were as previously described [8] . Patients with systemic syndrome were excluded from this study. The control subjects were identified by physical examination and detailed history, and they had no symptoms or histories of DDH. All subjects in the study were unrelated Han Chinese living in or around Nanjing, Southern China. No subjects dropped out during the process of the study. The study was approved by the ethical committee of Drum Tower Hospital Affiliated to Medical School of Nanjing University, and informed consent was obtained from patients and controls.
Genotyping.
DNA was obtained from all the subjects from peripheral blood using the NucleoSpin Blood QuickPure Kit (Macherey-Nagel, German) according to the manufacturer's instructions. The SNP rs726252 was genotyped using TaqMan assay on an ABI 7500 real-time polymerase chain reaction (PCR) instrument (Applied Biosystems 7500, ABI, Foster City, CA, USA). Genotyping was performed by laboratory personnel blinded to case status, and two authors independently reviewed the genotyping results, data entry, and statistical analyses.
Statistics.
In this case-control study, we used standard chi-square analysis to compare the PAPPA2 genotype and allele distributions. Hardy-Weinberg equilibrium was also performed by chi-square test. The associations between PAPPA2 variants and DDH risk were evaluated by computing the odds ratios (ORs) and 95% confidence intervals (CIs) stratified by gender and severity. Meta-analysis of two studies was also conducted. All these statistical analyses were performed with SAS 9.1.3 software (SAS Institute, Cary, NC). The results were shown in Tables 1, 2 , 3, and 4.
Result
The ages of DDH patients and controls (mean ± SD) were 23.2 ± 11.8 months (range, 2 to 83 months) and 56.2 ± 12.7 years (range, 34 to 76 years), respectively. The distributions of the alleles and genotypes for rs726252 are presented in Table 1 . Distributions of genotypes in the DDH and control groups were conformed to Hardy-Weinberg equilibrium ( = 0.75 and 0.36, resp.). The minor allele frequency of rs726252 of controls in our study was 0.11, and it was closer to that reported in HapMap for Chinese Han populations (0.08) than the previous study [12] . We compared the genotype frequencies and allele frequencies between the patients and the controls; no significant difference was observed ( = 0.59 and 0.36, resp.). No significant difference was found in any comparison after stratification by gender and severity of DDH (Tables 2 and 3 ). We also compared allele frequency and genotype distribution in subjects between our study and the previous one. We found a significant difference of genotype distribution between our cases and Jia's cases ( = 0.011) and significant differences of allele frequency and genotype between our control subjects and Jia's control subjects ( = 0.0001 and 0.0002, resp.) (Table 4 ). In meta-analysis for the two studies, ORs of risk allele frequency (RAF) in casecontrol study are shown in Figure 1 , ORs of RAF when stratified by gender are shown in Figures 2 and 3 . Both in Figures 1 and 2 , the allelic ORs are less than 1; however, in Figure 3 , we found that OR in our study is different from Jia's.
Discussion
In this study, a total of 1404 individuals were analyzed. For this SNP (rs726252), we did not detect any significant difference in genotype distribution or allele frequency between cases and controls, even after stratification by gender and severity of DDH. Our study indicated that rs726252 in PAPPA2 had no association with susceptibility to DDH in the Chinese Han population. Thus, our results do not support the previous results [12] .
By comparison of allele frequency and genotype distribution in subjects between the two studies, there was no significant difference in comparison of allele frequency between our cases and Jia's cases, but significant difference of genotype distribution was found between the case subjects in two studies. Significant differences were found in comparison of allele frequency and genotype distribution between control subjects in the two studies ( = 0.0001 and 0.0002, resp.). We checked this SNP in HapMap database; the minor allele frequency was 0.08, and the minor allele frequency of control subjects of the two studies was 0.11 and 0.16. The minor allele frequency of this SNP of control subjects in our study was closer to that in Chinese population of HapMap database. The sample size in our study is twice larger than theirs, and it makes our data more reliable. So we inferred that there might be a sampling error in the previous study. Although the genetic difference between Southern China and North China is very small [17] , it is also a potential influence factor for the different results. Test for overall effect: Z = 1.49 (P = 0.14) There are also several limitations in the current study. First, due to low prevalence of DDH in males, the number of male subjects in our study was relatively limited. The sample size of hip instability and subluxation was also limited. We are continuously collecting both male and female subjects. Second, we only tested one SNP, rs726252 in the present study. We can only deny the association between this SNP and DDH. The association between this gene and DDH is still suspicious.
In conclusion, our replication study indicated that there was no association between rs726252 and DDH in Chinese Han population. The association between PAPPA2 and DDH was suspicious and it still needed further evaluation.
